- Home
- ALT vs FPH Comparison
ALT vs FPH Comparison
Compare ALT & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- FPH
- Stock Information
- Founded
- ALT 1997
- FPH 2009
- Country
- ALT United States
- FPH United States
- Employees
- ALT N/A
- FPH N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- FPH Real Estate
- Sector
- ALT Health Care
- FPH Finance
- Exchange
- ALT Nasdaq
- FPH Nasdaq
- Market Cap
- ALT 292.0M
- FPH 390.0M
- IPO Year
- ALT N/A
- FPH 2017
- Fundamental
- Price
- ALT $3.83
- FPH $5.68
- Analyst Decision
- ALT Strong Buy
- FPH
- Analyst Count
- ALT 6
- FPH 0
- Target Price
- ALT $17.40
- FPH N/A
- AVG Volume (30 Days)
- ALT 3.0M
- FPH 150.3K
- Earning Date
- ALT 08-12-2025
- FPH 10-16-2025
- Dividend Yield
- ALT N/A
- FPH N/A
- EPS Growth
- ALT N/A
- FPH 46.82
- EPS
- ALT N/A
- FPH 1.08
- Revenue
- ALT $20,000.00
- FPH $197,429,000.00
- Revenue This Year
- ALT N/A
- FPH N/A
- Revenue Next Year
- ALT $761,880.20
- FPH N/A
- P/E Ratio
- ALT N/A
- FPH $5.28
- Revenue Growth
- ALT N/A
- FPH N/A
- 52 Week Low
- ALT $2.90
- FPH $3.10
- 52 Week High
- ALT $11.16
- FPH $6.71
- Technical
- Relative Strength Index (RSI)
- ALT 51.79
- FPH 56.60
- Support Level
- ALT $3.35
- FPH $5.51
- Resistance Level
- ALT $3.66
- FPH $5.77
- Average True Range (ATR)
- ALT 0.19
- FPH 0.14
- MACD
- ALT 0.07
- FPH 0.04
- Stochastic Oscillator
- ALT 86.18
- FPH 95.83
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.